中文

Scientific research, teaching and training are
in line with international standards

ROMA Trial

As early as May 2020, Jilin Heart Hospital exclusively contributed 18.1% of the scientific experimental data. To date, as a primary contributor to the ROMA Trial, Jilin Heart Hospital has enrolled 790 patients, making it the top global recruiter among all participating centers. Due to its outstanding performance, Jilin Heart Hospital has become one of the leading participants in the ROMA Trial, making exceptional contributions to the development and research of human cardiac surgery.

Trial Steering Committee
Jilin Heart Hospital is the only Asian member selected for the ROMA Trial Steering Committee. This Steering Committee comprises 13 top-tier cardiac surgery hospitals from 8 countries worldwide, including the Cleveland Clinic (USA), Weill Cornell Medical Center (USA), and Leipzig Heart Center (Germany). To date, over 80 hospitals globally are participating in the ROMA Trial.

Perceval S Sutureless Aortic Valve Clinical Trial for China Registration – PERFECT Investigator Meeting and Surgeon Training

In December 2017, Dr. Moriggia and Academician Hu Shengshou from Fuwai Hospital performed China's first Perceval Sutureless Valve implantation surgery.

The Perceval S sutureless aortic valve replacement is an innovative surgical approach that can shorten cardiopulmonary bypass and aortic cross-clamp times, thereby benefiting patients undergoing the procedure.

Jilin Heart Hospital collaborates with European universities to train specialist physicians.
Annalisa Francescato MD
In October 2019, Dr. Annalisa Francescato completed her cardiac surgery specialist training at Jixin and earned a Ph.D. in Cardiac Surgery from the University of Padua. She was the first specialist physician trained by a Chinese hospital to obtain Italian qualification certification.
Emanuele Sagazio
In December 2019, Dr. Emanuele Sagazio completed his cardiology specialist training at Jixin and obtained Italian Cardiology Specialist certification.
Silvia Corona MD
In December 2020, Dr. Silvia Corona completed her cardiac surgery specialist training at Jixin, earning a Ph.D. in Cardiac Surgery from the University of Milan and Italian specialist qualification certification.
National Training
July 28, 2024: Jilin Heart Hospital hosted the International Coronary Surgery Seminar
October 31, 2023: Jilin Heart Hospital co-organized the 2023 National Public Welfare Training Program for Medical and Management Talents in Privately-run Healthcare - Specialized Training in Cardiovascular and Cerebrovascular Disciplines
July 31, 2023: Jilin Heart Hospital hosted the International Coronary Surgery Summit Forum
March 29, 2019: Jilin Heart Hospital hosted the "Minimally Invasive China Tour - International Training Course on Minimally Invasive Bypass Surgery"
April 21, 2018: Jilin Heart Hospital hosted the "Ethicon Skills Forum - Vascular Anastomosis Technique Training"
July 21, 2017: MICS-CABG Total Arterial Minimally Invasive Bypass National Training


More than 80 cardiac surgery experts from hospitals in over 30 provinces and cities across China gathered at Jilin Heart Hospital to participate in technical training. Among these institutions were industry leaders such as Fuwai Hospital, Beijing Anzhen Hospital, and Beijing 301 Hospital, as well as hospitals representing the highest-level cardiac medical institutions in their respective provinces and cities, including the First Affiliated Hospital of Zhejiang University School of Medicine, the First Affiliated Hospital of Xi'an Jiaotong University, Xijing Hospital, the Second Xiangya Hospital of Central South University, and Zhongshan Hospital affiliated with Fudan University.